USPTO serial 76209727
PANGENEX
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- CLARK, GLENN
- Law office
- INTENT TO USE UNIT
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PANGENEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joanne Ludovici-Lint
JOANNE LUDOVICI-LINT MCDERMOTT WILL & EMERY600 13TH ST NWWASHINGTON, DC 20005-3096UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations used in the treatment of cancer and genetic disorders; pharmaceutical preparations used in the field of gene therapy; and diagnostic preparations for medical laboratory use | ACTIVE | — |
| 009 | Computer hardware; Computer software used for conducting research and testing in the field of pharmaceuticals, medicine, cancer, genetic disorders and gene therapy; electronic databases recorded on computer tapes and discs featuring information in the field of pharmaceuticals, medicine, cancer, genetic disorders, gene therapy, and laboratory testing; prerecorded audio and video tapes and discs featuring information in the fields of pharmaceuticals, medicine, cancer, genetic disorders, gene therapy and laboratory testing, and user manuals sold as a unit therewith | ACTIVE | — |
| 042 | pharmaceutical, medical and laboratory research and testing services in the field of pharmaceuticals, cancer, genetic disorders and gene therapy; medical service, namely, gene therapy; medical research in the field of gene therapy; genome and DNA research services; providing information in the field of pharmaceuticals, medicine, cancer, genetic disorders and gene therapy; providing an online magazine in the fields of pharmaceuticals, medicine, cancer, genetic disorders and gene therapy, and consultation related to the foregoing | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PanGenex, Inc.
- Other trademarks owned by PanGenex, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named PANGENEX
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 1, 2006 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 1, 2006 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 11, 2005 | EX5G | SOU EXTENSION 5 GRANTED | — |
| May 11, 2005 | EXT5 | SOU EXTENSION 5 FILED | — |
| May 11, 2005 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 22, 2004 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Nov 16, 2004 | EXT4 | SOU EXTENSION 4 FILED | — |
| Nov 16, 2004 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 4, 2004 | EX3G | SOU EXTENSION 3 GRANTED | — |
| May 28, 2004 | CFIT | CASE FILE IN TICRS | — |
| May 18, 2004 | EXT3 | SOU EXTENSION 3 FILED | — |
| May 18, 2004 | PAPER RECEIVED | — | |
| Apr 26, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 23, 2003 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 26, 2003 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 26, 2003 | PAPER RECEIVED | — | |
| Jun 18, 2003 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 23, 2003 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 23, 2003 | PAPER RECEIVED | — | |
| Nov 26, 2002 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 3, 2002 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 14, 2002 | NPUB | NOTICE OF PUBLICATION | — |
| May 27, 2002 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 19, 2002 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Dec 12, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 19, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2001 | DOCK | ASSIGNED TO EXAMINER | — |